Clinical Research

HOME > R&D Achievement > Clinical Research > Article
 
DATE : 16-03-14 13:34
Very late stent thrombosis after drug-eluting stent implantation in a patient without aspirin and clopidogrel resistance.
 WRITER : stent
HIT : 2,444  
   C70._J_Korean_Med_Sci._2008;23_3_556-559..pdf (442.8K) [0] DATE : 2016-03-14 13:34:10
C70. Lim SY, Kim KS, Joo SJ, Jeong MH; Very late stent thrombosis after drug-eluting stent implantation in a patient without aspirin and clopidogrel resistance. J Korean Med Sci. 2008;23(3)556-559.

(Abstract)
Very late stent thrombosis (VLST) after implantation of drug-eluting stent is rare, but very fatal complication after percutaneous coronary intervention. We report a case of VLST of a sirolimus-eluting Cypher stent (Cordis, Johnson and Johnson) presenting as acute ST elevation myocardial infarction at 26 months after deployment with continued combined dual antiplatelet medication of aspirin and clopidogrel. The patient did not show anti-platelet resistance.